Sinusitis Studies For Nonantimicrobial Drugs Need Objective Endpoints – FDA
Executive Summary
Clinical trials assessing nonantimicrobial drugs for treatment of acute, subacute or chronic sinusitis should include at least one objective endpoint to establish efficacy, an FDA 1draft guidance recommendsYou may also be interested in...
Sinusitis Trials Should Use Superiority Instead Of Non-Inferiority Design – Cmte.
Clinical trials for acute bacterial sinusitis therapies should be designed to show superiority of the investigative antimicrobial to placebo, members of FDA's Anti-Infective Drugs Advisory Committee said Oct. 29
Hologic's Adiana Permanent Birth Control Device Takes On Conceptus' Essure
Adiana uses a polymer matrix insert to block the fallopian tubes instead of a metal coil, offering a benefit over Essure, which carries a perforation risk on implantation, Hologic exec says.
MADIT-CRT Data Support Expanded Cardiac Resynchronization Market
The results show that cardiac resynchronization defibrillators "slow the progression of heart failure in asymptomatic and mildly symptomatic patients," potentially expanding the market by $600 million.
Existing Subscriber?
Sign in to continue reading.
Need a specific report? 1000+ reports available
Buy Reports
Need a specific report? 1000+ reports available
Buy Reports
New to Pink Sheet?
Start a free trial today!
Register for our free email digests:
Register for our free email digests: